Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy

Nivolumab plus ipilimumab combined therapy is one of the promising drugs that enhance the anti- immune response in patients with advanced melanoma. Therefore, to increase its response rate is of great interest to dermatologists. Recent reports suggested that, since CD8+ T cells after the administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Saaya, Fujimura, Taku, Kambayashi, Yumi, Amagai, Ryo, Hashimoto, Akira, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872996/
https://www.ncbi.nlm.nih.gov/pubmed/31762756
http://dx.doi.org/10.1159/000504019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872996/
https://www.ncbi.nlm.nih.gov/pubmed/31762756
http://dx.doi.org/10.1159/000504019

Ejemplares similares